File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Side effects and good effects from new chemotherapeutic agents: Case 3. Bortezomib in primary refractory plasmacytoma

TitleSide effects and good effects from new chemotherapeutic agents: Case 3. Bortezomib in primary refractory plasmacytoma
Authors
Chim, CSOoi, GCLoong, FAu, AWMLie, AKW
Issue Date2005
PublisherAmerican Society of Clinical Oncology. The Journal's web site is located at http://www.jco.org/
Citation
Journal Of Clinical Oncology, 2005, v. 23 n. 10, p. 2426-2428 How to Cite?
DOI: http://dx.doi.org/10.1200/JCO.2005.04.079
Persistent Identifierhttp://hdl.handle.net/10722/162821
ISSN
0732-183X
2023 Impact Factor: 42.1
2023 SCImago Journal Rankings: 10.639
ISI Accession Number ID
WOS:000228260200039
References
References in Scopus

 

DC FieldValueLanguage
dc.contributor.authorChim, CSen_US
dc.contributor.authorOoi, GCen_US
dc.contributor.authorLoong, Fen_US
dc.contributor.authorAu, AWMen_US
dc.contributor.authorLie, AKWen_US
dc.date.accessioned2012-09-05T05:23:56Z-
dc.date.available2012-09-05T05:23:56Z-
dc.date.issued2005en_US
dc.identifier.citationJournal Of Clinical Oncology, 2005, v. 23 n. 10, p. 2426-2428en_US
dc.identifier.issn0732-183Xen_US
dc.identifier.urihttp://hdl.handle.net/10722/162821-
dc.languageengen_US
dc.publisherAmerican Society of Clinical Oncology. The Journal's web site is located at http://www.jco.org/en_US
dc.relation.ispartofJournal of Clinical Oncologyen_US
dc.subject.meshAntineoplastic Agents - Therapeutic Useen_US
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols - Therapeutic Useen_US
dc.subject.meshBone Marrow Transplantationen_US
dc.subject.meshBoronic Acids - Therapeutic Useen_US
dc.subject.meshDisease-Free Survivalen_US
dc.subject.meshDrug Resistance, Neoplasmen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshMediastinal Neoplasms - Drug Therapy - Pathologyen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshPlasmacytoma - Drug Therapy - Pathologyen_US
dc.subject.meshPyrazines - Therapeutic Useen_US
dc.subject.meshTreatment Outcomeen_US
dc.titleSide effects and good effects from new chemotherapeutic agents: Case 3. Bortezomib in primary refractory plasmacytomaen_US
dc.typeArticleen_US
dc.identifier.emailChim, CS:jcschim@hku.hken_US
dc.identifier.authorityChim, CS=rp00408en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1200/JCO.2005.04.079en_US
dc.identifier.pmid15800336-
dc.identifier.scopuseid_2-s2.0-17144362510en_US
dc.identifier.hkuros99013-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-17144362510&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume23en_US
dc.identifier.issue10en_US
dc.identifier.spage2426en_US
dc.identifier.epage2428en_US
dc.identifier.isiWOS:000228260200039-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridChim, CS=7004597253en_US
dc.identifier.scopusauthoridOoi, GC=7006176119en_US
dc.identifier.scopusauthoridLoong, F=6602794154en_US
dc.identifier.scopusauthoridAu, AWM=8333070500en_US
dc.identifier.scopusauthoridLie, AKW=24284842400en_US
dc.identifier.issnl0732-183X-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats